Close Menu

NEW YORK (GenomeWeb) – NanoString said after the close of the market Thursday that it has signed commercial partnerships with three contract research organizations to expand commercial access to its PanCancer IO 360 Gene Expression Panel.

The deals with Covance, NeoGenomics Laboratories, and Navigate BioPharma Services will have two main areas of focus. First, NanoString will enable the CROs to offer and deliver a standardized research report that currently captures 47 gene expression signatures measuring the activity and abundance of immune and tumor cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.